Evidence map›Paper›PMID 38281495›Full record

Observational studyThe Lancet. Child & adolescent health2024

Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational study.

Sana Mahtab, Dianna M Blau, Zachary J Madewell, Ikechukwu Ogbuanu, Julius Ojulong, Sandra Lako, Hailemariam Legesse, Joseph S Bangura, Quique Bassat, Inacio Mandomando and 31 more

Abstract readObservational Study
In one paragraph

Observational study in The Lancet. Child & adolescent health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genomic analysis ofbioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Genomic Characterization ofOpen forum infectious diseases · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

41 authors.

Sana MahtabSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Dianna M BlauGlobal Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Zachary J MadewellGlobal Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ikechukwu OgbuanuCrown Agents, Freetown, Sierra Leone.
Julius OjulongICAP - Columbia University, Makeni, Sierra Leone.
Sandra LakoAberdeen Women's Centre, Freetown, Sierra Leone.
Hailemariam LegesseUNICEF Sierra Leone, Freetown, Sierra Leone.
Joseph S BanguraCaritas International-Sierra Leone, Freetown, Sierra Leone.
Quique BassatCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal - Hospital Clínic, Unversitat de Barcelona, Barcelona, Spain; Institutó Catalana de Recerca I Estudis Avançats, Barcelona, Spain; Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.
Inacio MandomandoCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Instituto Nacional de Saúde, Maputo, Mozambique.
Elisio XerindaCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Fabiola FernandesDepartment of Pathology, Maputo Central Hospital, Maputo, Mozambique.
Rosauro VaroCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal - Hospital Clínic, Unversitat de Barcelona, Barcelona, Spain.
Samba O SowCentre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
Karen L KotloffDepartment of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Milagritos D TapiaDepartment of Pediatrics and Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Adama Mamby KeitaCentre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
Diakaridia SidibeCentre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
Dickens OnyangoKisumu County Department of Health, Kisumu, Kenya.
Victor AkeloCenters for Disease Control and Prevention-Kenya, Kisumu, Kenya.
Dickson GethiKenya Medical Research Institute-Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Jennifer R VeraniNational Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Gunturu RevathiDepartment of Pathology, Aga Khan University, Nairobi, Kenya.
J Anthony G ScottDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Nega AssefaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Lola MadridDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Hiwot BizuayehuDepartment of Microbiology, Addis Ababa Burn, Emergency and Trauma Hospital, Addis Ababa, Ethiopia.
Tseyon Tesfaye TirfeCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Shams El ArifeenInternational Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
Emily S GurleyInternational Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Kazi Munisul IslamInternational Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
Muntasir AlamInternational Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
Mohammad Zahid HossainInternational Center for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
Ziyaad DangorSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Vicky L BaillieSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Martin HaleNational Health Laboratory Service, Department of Anatomical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Portia MutevedziEmory Global Health Institute, Emory University, Atlanta, Georgia, USA.
Robert F BreimanWits Infectious Diseases and Oncology Research Institute, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
Cynthia G WhitneyEmory Global Health Institute, Emory University, Atlanta, Georgia, USA.
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa. Electronic address: shabir.madhi@wits-vida.org.
CHAMPS Consortium

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundThe Child Health and Mortality Prevention Surveillance (CHAMPS) Network programme undertakes post-mortem minimally invasive tissue sampling (MITS), together with collection of ante-mortem clinical information, to investigate causes of childhood deaths across multiple countries. We aimed to evaluate the overall contribution of pneumonia in the causal pathway to death and the causative pathogens of fatal pneumonia in children aged 1-59 months enrolled in the CHAMPS Network.

methodsIn this observational study we analysed deaths occurring between Dec 16, 2016, and Dec 31, 2022, in the CHAMPS Network across six countries in sub-Saharan Africa (Ethiopia, Kenya, Mali, Mozambique, Sierra Leone, and South Africa) and one in South Asia (Bangladesh). A standardised approach of MITS was undertaken on decedents within 24-72 h of death. Diagnostic tests included blood culture, multi-organism targeted nucleic acid amplifications tests (NAATs) of blood and lung tissue, and histopathology examination of various organ tissue samples. An interdisciplinary expert panel at each site reviewed case data to attribute the cause of death and pathogenesis thereof on the basis of WHO-recommended reporting standards.

findingsPneumonia was attributed in the causal pathway of death in 455 (40·6%) of 1120 decedents, with a median age at death of 9 (IQR 4-19) months. Causative pathogens were identified in 377 (82·9%) of 455 pneumonia deaths, and multiple pathogens were implicated in 218 (57·8%) of 377 deaths. 306 (67·3%) of 455 deaths occurred in the community or within 72 h of hospital admission (presumed to be community-acquired pneumonia), with the leading bacterial pathogens being Streptococcus pneumoniae (108 [35·3%]), Klebsiella pneumoniae (78 [25·5%]), and non-typeable Haemophilus influenzae (37 [12·1%]). 149 (32·7%) deaths occurred 72 h or more after hospital admission (presumed to be hospital-acquired pneumonia), with the most common pathogens being K pneumoniae (64 [43·0%]), Acinetobacter baumannii (19 [12·8%]), S pneumoniae (15 [10·1%]), and Pseudomonas aeruginosa (15 [10·1%]). Overall, viruses were implicated in 145 (31·9%) of 455 pneumonia-related deaths, including 54 (11·9%) of 455 attributed to cytomegalovirus and 29 (6·4%) of 455 attributed to respiratory syncytial virus.

interpretationPneumonia contributed to 40·6% of all childhood deaths in this analysis. The use of post-mortem MITS enabled biological ascertainment of the cause of death in the majority (82·9%) of childhood deaths attributed to pneumonia, with more than one pathogen being commonly implicated in the same case. The prominent role of K pneumoniae, non-typable H influenzae, and S pneumoniae highlight the need to review empirical management guidelines for management of very severe pneumonia in low-income and middle-income settings, and the need for research into new or improved vaccines against these pathogens.

fundingBill & Melinda Gates Foundation.

Indexed as

PneumoniaAsia, SouthernChildChild MortalityHumansInfantSouth AfricaStreptococcus pneumoniae

Identifiers

PMID38281495
PMCPMC10864189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.